Ryosuke Tateishi Selected Research

Ryosuke Tateishi Research Topics

Disease

87	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 05/2004
42	Neoplasms (Cancer) 04/2022 - 01/2003
17	Chronic Hepatitis C 07/2021 - 07/2004
13	Fibrosis (Cirrhosis) 01/2022 - 09/2008
13	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 12/2005
12	Liver Diseases (Liver Disease) 01/2022 - 02/2007
9	Infections 01/2021 - 04/2005
6	Non-alcoholic Fatty Liver Disease 01/2022 - 12/2018
6	Neoplasm Metastasis (Metastasis) 03/2013 - 11/2008
5	Thrombocytopenia (Thrombopenia) 01/2022 - 08/2010
5	Hepatitis C 01/2022 - 01/2009
5	Carcinogenesis 01/2022 - 04/2005
5	Liver Neoplasms (Liver Cancer) 09/2020 - 07/2004
4	Hemorrhage 01/2022 - 04/2016
4	Disease Progression 01/2020 - 01/2012
3	Necrosis 04/2022 - 01/2012
3	Obesity 07/2021 - 01/2018
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 10/2009
2	Cholecystitis 09/2021 - 08/2020
2	Cholangitis 09/2021 - 04/2017
2	Hypertension (High Blood Pressure) 01/2021 - 04/2017
2	Drug-Related Side Effects and Adverse Reactions 08/2020 - 10/2014
2	Virus Diseases (Viral Diseases) 12/2019 - 01/2012
2	Cholangiocarcinoma 09/2019 - 12/2017
2	Pain (Aches) 09/2017 - 03/2011
2	Chronic Hepatitis (Chronic Active Hepatitis) 06/2015 - 01/2003
2	Hepatitis 01/2009 - 01/2008
1	Thyroid Neoplasms (Thyroid Cancer) 09/2021
1	Pancreatitis 09/2021
1	Inflammation (Inflammations) 09/2021
1	Dyslipidemias (Dyslipidemia) 07/2021

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 04/2022 - 11/2008
13	Antiviral Agents (Antivirals)IBA 01/2022 - 07/2004
10	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022 - 05/2005
10	Tumor Biomarkers (Tumor Markers)IBA 09/2019 - 12/2006
9	InterferonsIBA 07/2021 - 05/2004
7	AlbuminsIBA 04/2022 - 05/2005
7	Ethanol (Ethyl Alcohol)IBA 01/2018 - 11/2004
5	Indicators and Reagents (Reagents)IBA 03/2019 - 08/2008
5	acarboxyprothrombin (PIVKA)IBA 01/2014 - 05/2005
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2022 - 01/2003
4	Alanine Transaminase (SGPT)IBA 04/2022 - 01/2003
4	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 08/2012
4	lentil lectinIBA 01/2014 - 12/2006
3	Pharmaceutical PreparationsIBA 01/2022 - 04/2005
3	lusutrombopagIBA 01/2022 - 02/2019
3	lenvatinibIBA 09/2021 - 01/2020
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 02/2011
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2012
3	Serum AlbuminIBA 01/2020 - 02/2007
3	LipidsIBA 01/2019 - 01/2018
3	Messenger RNA (mRNA)IBA 12/2018 - 05/2014
3	Interleukin-6 (Interleukin 6)IBA 02/2015 - 11/2009
3	AntigensIBA 11/2014 - 06/2011
3	orantinib (SU6668)IBA 10/2014 - 02/2011
3	Prothrombin (Factor II)IBA 04/2012 - 09/2008
2	Blood Proteins (Serum Proteins)IBA 01/2021 - 04/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 08/2020
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 10/2014
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 12/2018
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2021 - 02/2012
2	EnzymesIBA 09/2020 - 04/2005
2	acylcarnitineIBA 01/2019 - 01/2018
2	Hyaluronic Acid (Hyaluronan)IBA 07/2018 - 06/2011
2	IronIBA 01/2018 - 04/2016
2	Ferritins (Ferritin)IBA 01/2018 - 04/2016
2	AdiponectinIBA 02/2015 - 11/2011
2	RNA (Ribonucleic Acid)IBA 10/2014 - 04/2005
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2014 - 02/2011
2	Angiogenesis InhibitorsIBA 10/2014 - 02/2011
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2014 - 02/2011
2	Mitochondrial Form Creatine KinaseIBA 08/2014 - 05/2014
2	Contrast MediaIBA 01/2013 - 01/2010
2	Fluorouracil (Carac)FDA LinkGeneric 10/2012 - 05/2006
2	SonazoidIBA 04/2012 - 04/2011
2	Fetal Proteins (Fetoprotein)IBA 04/2012 - 10/2011
2	DNA (Deoxyribonucleic Acid)IBA 09/2011 - 11/2008
1	SREBP cleavage-activating proteinIBA 01/2022
1	N-propionyl-L-valine (A 195)IBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	clonidine-displacing substance (ClDS)IBA 01/2022
1	Sterol Regulatory Element Binding ProteinsIBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Translationally-Controlled 1 Tumor ProteinIBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021

Therapy/Procedure

42	Radiofrequency Ablation 04/2022 - 11/2004
35	Therapeutics 04/2022 - 05/2004
5	Hepatectomy 01/2022 - 01/2010
5	Drug Therapy (Chemotherapy) 01/2022 - 11/2010
4	Liver Transplantation 02/2015 - 05/2005
3	Platelet Transfusion (Blood Platelet Transfusions) 01/2022 - 12/2019
3	Aftercare (After-Treatment) 09/2021 - 09/2011
3	Renal Dialysis (Hemodialysis) 01/2019 - 10/2009
2	Molecular Targeted Therapy 01/2021 - 09/2019
2	Neoadjuvant Therapy 09/2020 - 11/2010
2	Catheters 10/2012 - 01/2010
1	Chemoprevention 01/2022
1	Bariatric Surgery 01/2022
1	Immunotherapy 01/2021